Project 2: ACHIEVE- HF

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHenry Ford Health System

About this trial

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves four separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Projects 2 and 4) and coronary heart disease (CHD, Project 3). The first three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. Projects 1-3 also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 2 of the ACHIEVE GREATER Center.

Eligibility criteria

Qualifiers

Detroit-area resident (defined as those who attended a Detroit-area community event)

≥18 years of age

Disqualifiers

Previous diagnosis of HF

Uncontrolled diabetes (HbA1C ≥8.0% from SOC screening labs)

Chronic use of insulin or >1 anti-diabetic medication

Self-reported pregnancy (or planning to become pregnant in the next year)

Trial design

Treatments tested in this trial

  • PAL2
  • PHARM-PAL2

Treatment groups

364 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Henry Ford Health System

Lead sponsor

Wayne State University

Collaborator